| 货号 |
中文名 |
英文名 |
品牌 |
规格 |
价格 |
详细 |
| LT1200-100 mg |
Anti-Human CD279 (PD-1) (Nivolumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100mg |
69300 |
More |
| LT1200-25 mg |
Anti-Human CD279 (PD-1) (Nivolumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25mg |
27650 |
More |
| LT1200-5 mg |
Anti-Human CD279 (PD-1) (Nivolumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5.0mg |
7700 |
More |
| LT1200-50 mg |
Anti-Human CD279 (PD-1) (Nivolumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50mg |
49000 |
More |
| LT1203-50 μg |
Anti-Human CD279 (PD-1) (Nivolumab) - APC Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
3038 |
More |
| LT1204-50 μg |
Anti-Human CD279 (PD-1) (Nivolumab) - PE Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
3038 |
More |
| LT1205-500 μg |
Anti-Human CD279 (PD-1) (Nivolumab) - Fc Muted? Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
500μg |
5530 |
More |
| LT1211-100 μg |
Anti-Human CD279 (PD-1) (Nivolumab) - Dylight? 488 Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4550 |
More |
| LT1300-1 mg |
Anti-Human OX40L (Oxelumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0mg |
2030 |
More |
| LT1300-100 mg |
Anti-Human OX40L (Oxelumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100mg |
69300 |
More |
| LT1300-25 mg |
Anti-Human OX40L (Oxelumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25mg |
27650 |
More |
| LT1300-5 mg |
Anti-Human OX40L (Oxelumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5.0mg |
7700 |
More |
| LT1300-50 mg |
Anti-Human OX40L (Oxelumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50mg |
49000 |
More |
| LT1303-50 μg |
Anti-Human OX40L (Oxelumab) - APC Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
3038 |
More |
| LT1304-50 μg |
Anti-Human OX40L (Oxelumab) - PE Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
3038 |
More |
| LT1305-500 μg |
Anti-Human OX40L (Oxelumab) - Fc Muted? Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
500μg |
5530 |
More |
| LT1311-100 μg |
Anti-Human OX40L (Oxelumab) - Dylight? 488 Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4550 |
More |
| LT1400-1 mg |
Anti-Human CD257 (BAFF) (Tabalumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0mg |
2030 |
More |
| LT1400-100 mg |
Anti-Human CD257 (BAFF) (Tabalumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100mg |
69300 |
More |
| LT1400-25 mg |
Anti-Human CD257 (BAFF) (Tabalumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25mg |
27650 |
More |
| LT1400-5 mg |
Anti-Human CD257 (BAFF) (Tabalumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5.0mg |
7700 |
More |
| LT1400-50 mg |
Anti-Human CD257 (BAFF) (Tabalumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50mg |
49000 |
More |
| LT1401-100 μg |
Anti-Human CD257 (BAFF) (Tabalumab) - Biotin Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4438 |
More |
| LT1404-50 μg |
Anti-Human CD257 (BAFF) (Tabalumab) - PE Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
3038 |
More |
| LT1405-500 μg |
Anti-Human CD257 (BAFF) (Tabalumab) - Fc Muted? Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
500μg |
5530 |
More |
| LT1406-100 μg |
Anti-Human CD257 (BAFF) (Tabalumab) - Fc Muted? Biotin Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4998 |
More |
| LT1407-100 μg |
Anti-Human CD257 (BAFF) (Tabalumab) - Fc Muted? HRP Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
5670 |
More |
| LT1411-100 μg |
Anti-Human CD257 (BAFF) (Tabalumab) - Dylight? 488 Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4550 |
More |
| LT1500-1.0 mg |
Anti-Human HER-2 (Trastuzumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0mg |
2030 |
More |
| LT1500-100 mg |
Anti-Human HER-2 (Trastuzumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100mg |
69300 |
More |
| LT1500-25 mg |
Anti-Human HER-2 (Trastuzumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25mg |
27650 |
More |
| LT1500-5.0 mg |
Anti-Human HER-2 (Trastuzumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5.0mg |
7700 |
More |
| LT1500-50mg |
Anti-Human HER-2 (Trastuzumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50mg |
49000 |
More |
| LT1501-100 μg |
Anti-Human HER-2 (Trastuzumab) - Biotin Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4438 |
More |
| LT1502-100 μg |
Anti-Human HER-2 (Trastuzumab) - HRP Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4046 |
More |
| LT1503-50 μg |
Anti-Human HER-2 (Trastuzumab) - APC Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
3038 |
More |
| LT1504-50 μg |
Anti-Human HER-2 (Trastuzumab) - PE Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
3038 |
More |
| LT1505-500 μg |
Anti-Human HER-2 (Trastuzumab) - Fc Muted? Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
500μg |
5530 |
More |
| LT1506-100 μg |
Anti-Human HER-2 (Trastuzumab) - Fc Muted? Biotin Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4998 |
More |
| LT1507-100 μg |
Anti-Human HER-2 (Trastuzumab) - Fc Muted? HRP Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
5670 |
More |
| LT1511-100 μg |
Anti-Human HER-2 (Trastuzumab) - Dylight? 488 Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4550 |
More |
| LT1600-1 mg |
Anti-Human CTLA-4 (Ipilimumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0mg |
2030 |
More |
| LT1600-100 mg |
Anti-Human CTLA-4 (Ipilimumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100mg |
69300 |
More |
| LT1600-25 mg |
Anti-Human CTLA-4 (Ipilimumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25mg |
27650 |
More |
| LT1600-5 mg |
Anti-Human CTLA-4 (Ipilimumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5.0mg |
7700 |
More |
| LT1600-50 mg |
Anti-Human CTLA-4 (Ipilimumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50mg |
49000 |
More |
| LT1601-100 μg |
Anti-Human CTLA-4 (Ipilimumab) - Biotin Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4438 |
More |
| LT1602-100μg |
Anti-Human CTLA-4 (Ipilimumab) - HRP Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4046 |
More |
| LT1605-500 μg |
Anti-Human CTLA-4 (Ipilimumab) - Fc Muted? Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
500μg |
5530 |
More |
| LT1606-100 μg |
Anti-Human CTLA-4 (Ipilimumab) - Fc Muted? Biotin Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100μg |
4998 |
More |
